RSS Feeds
The Promotion of Gabapentin
- Michael A. Steinman, MD;
- Mary-Margaret Chren, MD;
- C. Seth Landefeld, MD; and
- Lisa A. Bero, PhD
- From San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California.
IN RESPONSE:
Dr. Finucane's enumeration of the large variety of controlled clinical trials of gabapentin is consistent with the company's support of small research projects to promulgate messages about the drug in the medical literature. Although one might apply principles of evidence-based medicine to each of these studies, in practice it is difficult for physicians to critically evaluate the effectiveness of gabapentin for such a wide range of disorders.
We applaud the positive steps outlined by Mr. Peterson and colleagues to reduce commercial influence on educational activities. However, we remain skeptical of the claim that the practices we identified are only of historical interest. Current codes of …
